These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 17680316

  • 1. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
    Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH.
    Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
    [Abstract] [Full Text] [Related]

  • 2. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ.
    Hepatogastroenterology; 1997 Oct; 44(17):1488-94. PubMed ID: 9356878
    [Abstract] [Full Text] [Related]

  • 3. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H, Takano Y.
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [Abstract] [Full Text] [Related]

  • 4. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H.
    Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
    [Abstract] [Full Text] [Related]

  • 5. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N, Tanabe S, Mikami T, Okayasu I, Saigenji K.
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [Abstract] [Full Text] [Related]

  • 6. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
    Polkowski WP, Skomra DG, Mielko J, Wallner GT, Szumiło J, Zinkiewicz K, Korobowicz EM, van Lanschot JJ.
    Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF, Takano Y.
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of T antigen expression in patients with gastric carcinoma.
    Chung YS, Yamashita Y, Kato Y, Nakata B, Sawada T, Sowa M.
    Cancer; 1996 May 01; 77(9):1768-73. PubMed ID: 8646672
    [Abstract] [Full Text] [Related]

  • 9. CD24 expression has a prognostic impact in breast carcinoma.
    Athanassiadou P, Grapsa D, Gonidi M, Athanassiadou AM, Tsipis A, Patsouris E.
    Pathol Res Pract; 2009 May 01; 205(8):524-33. PubMed ID: 19243896
    [Abstract] [Full Text] [Related]

  • 10. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
    Chatterjee D, Sabo E, Tavares R, Resnick MB.
    Clin Cancer Res; 2008 May 15; 14(10):2994-3001. PubMed ID: 18483365
    [Abstract] [Full Text] [Related]

  • 11. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC, Hsu C, Kao HL, Jeng YM.
    Cancer Lett; 2006 Apr 08; 235(1):34-9. PubMed ID: 16125303
    [Abstract] [Full Text] [Related]

  • 12. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM.
    Ann Surg Oncol; 2007 Oct 08; 14(10):2721-9. PubMed ID: 17564748
    [Abstract] [Full Text] [Related]

  • 13. Impact of lymphovascular invasion in patients with stage I gastric cancer.
    Kunisaki C, Makino H, Kimura J, Takagawa R, Kosaka T, Ono HA, Akiyama H, Fukushima T, Nagahori Y, Takahashi M.
    Surgery; 2010 Feb 08; 147(2):204-11. PubMed ID: 19878963
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.
    Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
    Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, Sabo E, Moss SF.
    Hum Pathol; 2005 Aug 15; 36(8):886-92. PubMed ID: 16112005
    [Abstract] [Full Text] [Related]

  • 18. Multivariate prognostic study on large gastric cancer.
    Shiraishi N, Sato K, Yasuda K, Inomata M, Kitano S.
    J Surg Oncol; 2007 Jul 01; 96(1):14-8. PubMed ID: 17582596
    [Abstract] [Full Text] [Related]

  • 19. CD24 expression is associated with progression of gastric cancer.
    Takahashi M, Nakajima M, Ogata H, Domeki Y, Ohtsuka K, Ihara K, Kurayama E, Yamaguchi S, Sasaki K, Miyachi K, Kato H.
    Hepatogastroenterology; 2013 Jun 01; 60(124):653-8. PubMed ID: 23159387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.